Related Experiment Video
Updated: May 9, 2026
Primary Culture of Mouse Dopaminergic Neurons
Published on: September 8, 2014
Methyl 3,4-dihydroxybenzoate protects primary cortical neurons against Aβ₂₅₋₃₅-induced neurotoxicity through
Xiao-Wen Zhou1, Zheng Zhang, Chao-Fen Su
1Department of Pharmacology, School of Medicine, Jinan University, Guangzhou, China.
Abstract:
Amyloid-β peptides (Aβ), which can aggregate into oligomers or fibrils in neurons, play a critical role in the pathogenesis of Alzheimer's disease (AD). Methyl 3,4-dihydroxybenzoate (MDHB), a phenolic acid compound, has been reported to have antioxidative and neurotrophic effects. The present study investigated the neuroprotective effects of MDHB against Aβ-induced apoptosis in rat primary cortical neutons. The primary cortical neurons were pretreated with different concentrations of MDHB for 24 hr, then incubated with 10 μM Aβ25-35 for 24 hr. The results showed that Aβ25-35 could induce neurotoxicity as evidenced by the decreased cell viability and the increased apoptotic rate. In parallel, Aβ25-35 significantly increased the reactive oxygen species accumulation and decreased mitochondrial membrane potential. However, pretreatment of the primary cortical neurons with MDHB could effectively suppress these cellular events caused by Aβ25-35 exposure. In addition, MDHB could increase the level of Bcl-2, decrease the level of Bax, and inhibit the activation of caspase-9 and caspase-3 in Aβ25-35 -treated primary cortical neurons. All these results were beneficial in their protective effect against Aβ-induced neurotoxicity. Our results suggest that MDHB has a neuroprotective effect that provides a pharmacological basis for its clinical use in the treatment of AD.
Insights
Methyl 3,4-dihydroxybenzoate (MDHB) protects neurons from Alzheimer's disease-related damage. This phenolic compound reduces amyloid-beta induced cell death and offers a potential therapeutic strategy for Alzheimer's disease.
Area of Science:
- Neuroscience
- Pharmacology
- Cell Biology
Background:
- Alzheimer's disease (AD) pathogenesis involves amyloid-beta (Aβ) peptide aggregation in neurons.
- Aβ peptides form toxic oligomers and fibrils, leading to neurodegeneration.
- Methyl 3,4-dihydroxybenzoate (MDHB) is a phenolic compound with known antioxidative and neurotrophic properties.
Purpose of the Study:
- To investigate the neuroprotective potential of MDHB against Aβ-induced apoptosis in primary cortical neurons.
- To elucidate the mechanisms underlying MDHB's protective effects against Aβ toxicity.
Main Methods:
- Primary rat cortical neurons were pretreated with varying concentrations of MDHB.
- Neurons were subsequently exposed to Aβ25-35 peptide to induce neurotoxicity.
- Cell viability, apoptosis rates, reactive oxygen species (ROS) levels, and mitochondrial membrane potential were assessed.
- Expression levels of apoptosis-related proteins (Bcl-2, Bax) and caspase activation were analyzed.
Main Results:
- Aβ25-35 exposure significantly reduced cell viability and increased apoptosis.
- Aβ25-35 induced increased ROS accumulation and decreased mitochondrial membrane potential.
- MDHB pretreatment effectively counteracted Aβ25-35-induced neurotoxicity.
- MDHB upregulated the anti-apoptotic protein Bcl-2, downregulated the pro-apoptotic protein Bax, and inhibited caspase-9 and caspase-3 activation.
Conclusions:
- MDHB exhibits significant neuroprotective effects against Aβ-induced neurotoxicity and apoptosis in primary cortical neurons.
- MDHB exerts its protective effects by mitigating oxidative stress, preserving mitochondrial function, and modulating apoptotic pathways.
- These findings support MDHB as a potential therapeutic agent for Alzheimer's disease.
More Related Videos
06:23Visualizing Axonal Growth Cone Collapse and Early Amyloid β Effects in Cultured Mouse Neurons
Published on: October 30, 2018
06:41Quantitative Analysis of Mitochondria-Associated Endoplasmic Reticulum Membrane (MAM) Stabilization in a Neural Model of Alzheimer's Disease (AD)
Published on: January 10, 2025
